What makes peanuts so allergenic? by Petersen Arnd et al.
 
J. Serb. Chem. Soc. 78 (3) 321–331 (2013)  UDC 634.58+616–022.8:641.3 
JSCS–4419 Review 
321 
REVIEW 
What makes peanuts so allergenic? 
ARND PETERSEN*, WOLF-MEINHARD BECKER and UTA JAPPE 
Division of Clinical and Molecular Allergology, Research Center Borstel, Airway Research 
Center North (ARCN), Member of the German Center for Lung Research, Borstel, Germany 
(Received 5 October 2012, revised 24 January 2013) 
Abstract: Peanut allergy belongs to one of the most severe food allergies. So 
far 12 peanut allergens have been registered by the IUIS Allergen Nomen-
clature Subcommittee. The different peanut allergens and factors that con-
tribute to allergenicity are described herein. Peanut contains several class I 
food allergens (especially Ara h 1, 2, 3) that are stable against heat denaturation 
and proteolytic digestion and represent storage proteins. These allergens are 
often associated with severe allergic reactions. Additionally, peanut contains 
class II food allergens (Ara h 5 and 8), where the IgE reactivity is caused by 
cross reactions to inhalant allergens. These allergens are mostly associated with 
mild to moderate allergic reactions. However, the severity of the symptoms 
may change by involvement of additional factors. The peanut matrix consists to 
about 50 % of lipids, and allergen–lipid associations have been shown for 
several peanut allergens. Further factors influencing allergenicity depend on 
the peanut variety, geographical differences and alterations in food processing. 
Finally, the physiological function of allergens and the mechanisms by which 
they interact with the immune system are further modulating factors. Thus, the 
specific allergen structure, matrix, genetic variations, geographic alterations 
and further augmentation factors are important parameters that induce and 
influence allergenicity. 
Keywords: allergenicity; augmentation factors; class I and II food allergens; 
epitope; IgE reactivity. 
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1. INTRODUCTION 
Peanut is one of the most hazardous sources of food allergens that can cause 
severe, sometimes even fatal, anaphylactic reactions. About 100 µg of peanut 
protein can provoke symptoms in allergic individuals.1 It is rather difficult to 
avoid peanuts, since they may occur as hidden allergens in exotic meals and as 
supplements, such as peanut oil in cosmetics. Due to their lipophilic matrix (pea-
nuts contain about 50 % of lipids2), peanut proteins are considerably adhesive 
and may be resistant to degradation. Possible sensitization routes are the gastro-
intestinal tract, the respiratory tract, the skin, as well as breast feeding. 
To answer the questions concerning peanut allergenicity, the complexity of 
peanut allergens, co-factors and interaction with the immune system at different 
interfaces have to be taken into account.  
Three topics should be considered:  
1. the structural characteristics of peanut allergens; 
2. additional factors that can increase allergenicity; 
3. mechanisms of sensitization by peanut allergens. 
2. STRUCTURAL CHARACTERISTICS OF PEANUT ALLERGENS 
The molecular structure is obviously related to allergenicity. The fact that 
allergens exist only in 1.5 % of the 9318 protein families3 suggests a correlation 
between molecular structure and allergenicity. This was further confirmed by 
studies of da Costa Santiago et al.,4 who demonstrated a correlation of aller-
genicity with structural uniqueness of proteins, while homologous proteins com-
mon in eukaryotic organisms and high amino acid conservation levels result in 
lower allergenicity or lead to immunological tolerance.  
However, little is known about the typical structural characteristics of aller-
gens.5 Allergens are glycoproteins or proteins with a molecular weight of 10 to 
70 kDa. They must carry at least two IgE-reactive epitopes to enable cross-link-
ing of IgE antibodies on effector cells to release mediators. The allergenic mole-
cules must be stable to reach the immune cells. Interestingly, low dosages cause 
allergy, since low concentrations increase Th2 cell activation. Usually allergens 
are readily soluble. The physiological functions of allergens also have to be con-
sidered as factors promoting allergenicity, although few publications exist on this 
particular subject: some allergens have been identified as proteases, protease in-
hibitors, transport proteins, regulatory proteins, storage proteins and defence pro-
teins. 
Subsequently, different peanut allergens and factors that contribute to aller-
genicity are described. Peanut allergens were identified by 2D immunoblotting 
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using sera from peanut allergic individuals. The protein spots were identified by 
tryptic mass fingerprinting and sequence homology was searched for in data-
bases.6 The complexity becomes evident when focusing on molecules of similar 
size but with different pI values. Many allergens consist of isoforms that differ 
from each other by exchange of one or a few amino acids and/or post-trans-
lational modifications.7,8 
The peanut allergens as they are listed by the IUIS Allergen Nomenclature 
Subcommittee are summarized in Table I. Twelve different allergens from peanut 
(Arachis hypogaea) are known: Ara h 1–Ara h 13. The structure of the allergens 
varies from polypeptides (e.g., oleosins), small molecules stabilized by disulfide 
bonds (e.g., Ara h 2) to complex post-translation modified glycoproteins that oli-
gomerize (e.g., Ara h 1). The physiological function of peanut allergens range 
from storage proteins, protease inhibitors, pathogenesis-related proteins (PR pro-
teins for defence) to transport proteins. 
TABLE I. Overview of the peanut allergens (Arachis hypogaea). PTM, post-translational 
modifications; glyc, glycosylation; S–S, disulfide bond; PR, pathogenesis-related protein 
(Becker et al.,9 modified) 
Allergen  MW / kDa  pI Structure  PTM  Function 
Ara h 1  62–69  6.0–6.4  Cupin, vicilin type, 
7S, trimer  glyc, S–S  Storage protein 
Ara h 2  17–18  5.5  Conglutin type, 2S 
albumin  S–S 
Storage protein, 
trypsin inhibitor 
Ara h 3.01  56–59  5.4–5.6  Cupin, legumin type, 
11S, hexamer 
glyc, S–S, 
α- and β-
subunits 
Storage protein 
Ara h 3.02 
(Ara h 4) 
Ara h 5  14  4.6  Profilin  –  Profilin 
Ara h 6  14  5.0  Conglutin type, 2S 
albumin  S–S  – 
Ara h 7  16–17  5.6–7.5  Conglutin type, 2S 
albumin  S–S  – 
Ara h 8  16–17  5.0  Bet v 1 homologous 
protein  –  PR-10, transport 
Ara h 9  9  9.3–9.5  Lipid transfer protein S–S  PR-14, lipid 
transport 
Ara h 10  16–18  9.4–9.6  Oleosin  –  Lipid transport 
Ara h 11  14  9.1  Oleosin  –  Lipid transport 
Ara h 1218 5  7.7  Defensin,  dimer  S–S  PR-12, defence 
Ara h 1318 5  8.2  Defensin,  dimer  S–S  PR-12, defence 
In contrast to pollen allergens that enter the organism without structural 
changes, peanuts are usually processed by roasting before consumption and sub-
sequently undergo digestion under acidic conditions by pepsin in the stomach 
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and in basic conditions in duodenum by pancreatic enzymes, before fragments 
(single allergens) reach the immune system, a complex procedure, which influ-
ences their allergenicity.10 
Food allergy is divided into two classes as described in Table II.11 Class I 
food allergy is characterized by systemic and more severe reactions, which is 
associated with allergens resistant to heat, proteases and digestion, allowing these 
allergens to pass the gastrointestinal tract without structural changes. This 
category of allergens in peanut contains Ara h 1, 2 and 3, which are known to be 
responsible for severe anaphylactic reactions after peanut consumption. 
TABLE II. Classification of food allergens into class I and II 
Parameter  Class I  Class II 
Sensitization route  Gastrointestinal  Inhalation 
Characteristics  Thermally and proteolytically 
stable 
Thermally and proteolytically 
unstable 
Symptoms Severe  reactions 
Anaphylaxis 
Often mild reactions 
OAS 
Examples  Ara h 1, 2 and 3  Ara h 5 and 8 
However, peanut also contains class II food allergens. In this case, the sen-
sitization is usually raised against pollen allergens via the respiratory tract. Due 
to cross-reactive IgE epitopes in peanut allergens, such molecules can cause al-
lergic reactions as well. Usually these allergens are thermally and proteolytically 
unstable, and often only mild symptoms are provoked. 
The following description of the class I and II allergens of peanut is based on 
the review of Becker et al.9 
2.1. Characteristics of class I food allergens of peanut 
Some of the peanut allergens reveal many sequential IgE-binding epitopes, 
e.g., Ara h 1 possesses 23 linear epitopes.12 Even after partial cleavage during di-
gestion, some IgE-binding epitopes remain on the fragments and probably cause 
histamine release.  
Ara h 1 and Ara h 3 belong to the cupin superfamily with a molecular struc-
ture formed by a β-barrel core domain and two additional conserved sequence 
motifs. Ara h 1 is a 7S globulin and belongs to the vicilin type. Hydrophobic 
patches are located at the ends of the molecule; they are the binding edges for the 
formation of Ara h 1 trimers.13 Ara h 3 tends to form hexamers. Its monomers 
are composed of an acidic and a basic subunit linked by a disulfide bond.14 Ara h 
3 is an 11S globulin and belongs to the legumin type. 
Ara h 2, 6 and 7 are members of the prolamin superfamily. They are alcohol 
soluble proline and glutamine rich storage proteins that show a specific, highly 
conserved cysteine pattern (C–Xn–C–Xn–C–C–Xn–C–X–C–Xn–C–Xn–C), 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/ ALLERGENICITY  OF  PEANUTS  325 
whereby Ara h 6 contains 10 cysteines. Ara h 2, 6 and 7 belong to the 2S albu-
mins. Ara h 2 is the most frequently recognized peanut allergen.15 Studies by 
Maleki et al.10 showed that the stability of this molecule is due to the four di-
sulfide bonds. Roasting and denaturating conditions with 8 M urea did not alter 
the secondary structure, as demonstrated by CD spectroscopy. However, the con-
formational structure is destroyed by reducing procedures.  
Ara h 9 also belongs to the prolamin superfamily, but to the subgroup of the 
non-specific lipid transfer proteins (LTP). The LTPs are largely distributed in 
fruits and vegetables and cause allergic reactions, especially in individuals of the 
Mediterranean region.16,17 The underlying molecule is stabilized by four disul-
fide bonds and belongs to the pathogenesis-related proteins (PR12-protein).11 
Two further families of peanut allergens are associated with lipids: the ole-
osins (Ara h 10 and 11) and the defensins (Ara h 12 and 1318). Oleosins are 
amphiphilic molecules that form a monolayer on oilbodies19 and peanut defen-
sins, isolated from lipophilic fractions, have recently been identified as IgE-
reactive components.18 Plant defensins are small, highly stable, cysteine-rich 
peptides that constitute a part of the innate immune system, primarily directed 
against fungal pathogens.20 
2.2. Characteristics of class II food allergens of peanut 
Class II food allergens in peanut are Ara h 5 and 8. Ara h 5 is a profilin.21 
Profilins are detectable in all eukaryotic cells and are involved in the formation 
of the cytoskeleton. Since they also exist in human cells, immune responses can 
only be elucidated to structurally and phylogenetically less related plant profi-
lins.22 Nevertheless, the structural differences to plant profilins are small. Cli-
nical relevance seems to be negligible. The symptoms, if any occur, are usually 
only mild.  
Ara h 8 is a Bet v 1-homologous protein (PR-10 protein)23,24 and a class II 
food allergen, since the sensitization (especially in Northern Europe) is caused by 
the major birch pollen allergen Bet v 1. This plant family is rather large and 
consists of many members of fruits and vegetables from Rosaceae and Apiaceae, 
respectively.25  
Even though the protein sequences can differ by 60 % among different 
members, the underlying 3D structure and surface identity (important for the 
antibody binding) are more similar. The characteristic 3D structure is formed by 
7 antiparallel β-sheets and 2 short α-helices. These allergens are unstable to heat 
and digestion and, therefore, often cause only mild reactions, e.g., the oral allergy 
syndrome (OAS).24 
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3. ADDITIONAL FACTORS INFLUENCING ALLERGENICITY 
For allergy development, the specific structure of the allergen/s in the con-
text of allergen exposure and the genetic background of the individual are of 
profound importance.  
Allergenicity can vary considerably due to the variety of the allergen sour-
ces, the form of protein extraction and the further processing.  
Comparing peanuts from different varieties and origins, a peanut species 
from Bali that showed nearly no Ara h 1 was evidenced by 2D PAGE and immu-
noblotting.26 It might be speculated that this was a hypoallergenic peanut variant. 
However, when the allergenicity of the peanut extract was determined, it was 
found to be comparable to those other varieties, which is probably due to com-
pensation with higher amounts of the other peanut allergens. This is a natural 
example that demonstrates that the elimination of a single allergen does not ne-
cessarily result in a lower overall allergenicity. 
The extraction conditions also play an important role. Under alkaline con-
ditions (carbonate buffer, pH 8), which mirrors the physiological conditions of 
peanut uptake in man, Ara h 1 and Ara h 3 are especially detectable, while under 
acidic conditions (acetate buffer, pH 5) oleosins and LTP (Ara h 9) appear more 
prominently.27 
When an attempt was made to improve the isolation of Ara h 8 from an 
extract,28 it was observed that lipophilic extraction by use of chloroform and me-
thanol29 produced a more efficient isolation, resulting in pure Ara h 8. It would 
not have been possible to identify the sera of Ara h 8-reactive patients in the 
usually isolated extract (carbonate buffer, pH 8). However, by application of the 
lipophilic extraction method, Ara h 8 could clearly be detected. This is a fact that 
has to be considered for diagnosis.  
A further interesting phenomenon was observed in these experiments: ex-
tracts prepared from roasted peanuts revealed a stronger IgE reactivity when 
compared to the extract from unroasted peanuts (personal communication). This 
may be due to roasting as Maillard products are formed30 by the reaction of car-
bohydrates and allergens, which was demonstrated for the peanut allergens Ara h 
1 and 2.10,13 
A lipophilic matrix can also have an important influence on the allergenicity 
of the molecules. Sancho et al.31 demonstrated that phosphatidylcholine induced 
conformational changes in the apple allergen Mal d 1 and allowed this allergen to 
penetrate the phosphatidylcholine vesicle. By this, the digestion of the Mal d 1 
was retarded, and the allergenicity was retained to a large extent. Since peanut 
consists of up to 50 % of lipids,2 evidence was found that lipids also interfere 
with the IgE binding and digestibility of Ara h 8. After roasting, some covalent 
Ara h 8–lipid oxidation products might have been generated. Recombinant Ara h 
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8 without lipids was degraded rapidly, while Ara h 8 isolated from roasted 
peanuts was resistant in gastrointestinal digestion experiments.28 
Not only Ara h 8, but also several other peanut allergens are associated with 
lipids. Thus, the lipid transfer protein Ara h 9, the oleosins, which float on the 
surface of oilbodies,19 Ara h 10 and 11, and finally plant defensins were iden-
tified as by-product when Ara h 8 was isolated by lipophilic extraction.18 
Besides the specific structure, the quantity of allergens can influence sensi-
tization as well. Fox et al.32 reported that high levels of environmental exposure 
to peanut during infancy caused higher rates of sensitizations. On the other hand, 
du Toit et al.33 showed that early consumption of peanuts in infancy seems to be 
associated with a low prevalence of peanut allergy. They determined a 10-fold 
lower prevalence for peanut allergy in Jewish children in Israel than in Jewish 
children in the U.K. Israeli children consume peanuts in high quantities in the 
first year of life, while U.K. infants avoid peanuts. Other probable factors arising 
by atopy, social class, genetic background and peanut allergenicity were ruled 
out in the study.33 This indicates that a window of opportunity might exist in 
early life that causes tolerance induction.34  
Furthermore, the route of the allergen exposure seems to be decisive. In 
peanut allergic patients, the proliferation of peanut-specific memory T-cells with 
the skin-homing factor CLA+ (cutaneous lymphocyte antigen) predominates, 
while peanut-tolerant groups have a mixed skin- and gastrointestinal-homing fac-
tor composition CLA+/α4β7+.35 These results further support the hypothesis that 
the initial route of allergen exposure in early life is crucial: allergic sensitization 
might occur via the skin, while passage via the gut induces tolerance.35 
Geographical parameters and environmental factors can also influence the 
occurrence of allergic reactions to specific allergens. Concerning peanut aller-
gens, a clear distribution of the North European population exposed mainly to 
birch pollen results in reactivity to the Bet v 1-homologous Ara h 8, while in the 
Mediterranean countries, the reactions are especially based on the lipid transfer 
proteins. This is probably caused by exposure to the marker allergen Pru p 3 from 
peach, which cross-reacts with Ara h 9.17,36 
Food processing habits can also influence sensitization. It is interesting to 
note that peanuts are usually cooked in China, while they are mainly roasted in 
other countries.37 Although peanut consumption is high in China, peanut allergy 
does not seem to be as prevalent as it is in the U.S.A. The reason might be due to 
the food processing. By cooking peanuts, some allergens may be washed out, 
while roasting can generate new stable allergenic epitopes, e.g., Maillard pro-
ducts.38  
Last but not least, factors such as alcoholic drinks, non-steroidal anti-inflam-
matory drugs (NSAIDs), exercise and menses can increase food allergic symp-
toms.39,40 
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4. WHAT ARE THE MECHANISMS OF THE SENSITIZATION BY PEANUT 
ALLERGENS? 
To understand the effect of allergenicity, it is important to investigate how 
specific allergens interact with the epithelium and the immune response-trig-
gering cells.  
Several food allergens have been identified as proteases, e.g., actinidin of 
kiwi (Act d 1), and Cavic et al.41 were able to demonstrate similar morphological 
changes and desquamation of epithelial cells after exposure to Act d 1 and with 
the house dust mite allergen Der p 1.42 Although no allergenic protease have 
hitherto been identified in peanut, it might be speculated that, for example, sub-
tilisin, a serine protease in peanut kernels,43 disrupts the tight junctions, thereby 
enabling peanut allergens passage through the epithelial barrier. 
The allergens Ara h 2, 6 and 7 show molecular similarities to the soybean 
trypsin inhibitor.10 This might result in incomplete digestion of allergens, which 
can consequently elucidate allergic reactions. Shreffler et al.44 demonstrated a 
binding of the glycoprotein Ara h 1 via its carbohydrate moiety (β-glucan) to 
CD209 on dendritic cells, the DC-SIGN (dendritic cell-specific intercellular ad-
hesion molecule 3 grabbing non-integrin). As a consequence, a shift towards Th2 
activation occurs, as shown in human in vitro experiments. The results corres-
pond to those obtained in studies of Royer et al.,45 which showed that several 
native allergens with a carbohydrate moiety (among them Ara h 1) can bind to 
the mannose receptor on dendritic cells (C-type lectin) causing Th2 cell pola-
rization. 
Khodoun and co-workers46 proved that components from peanut extract can 
activate complement in mice in vivo and in vitro and they also demonstrated this 
effect in vitro in man. C3a and to a lower degree Fcγ receptors were identified as 
contributing to peanut extract-induced anaphylactic shock. This was shown to 
occur without the involvement of the adaptive immune system. To date, the elu-
cidating components from peanut extract have not been identified.  
Furthermore, the association of proteins with lipids and lipophilic molecules 
can have structural and functional effects. Karp47 hypothesized that intrinsic ad-
juvant activity may be provided for by the association of the proteins with their 
lipid cargo and that this underlies their immunogenicity and/or allergenicity. In 
this context, Ara h 8 and other lipophilic allergens may support or enhance the 
binding to receptors of the innate immune system, such as the Toll-like receptors 
TLR2 and TLR4 that bind lipopeptides and lipopolysaccharides (LPS), respecti-
vely. Dependent on the LPS concentration, the immune responses can vary con-
siderably. In an animal model with ovalbumin, a dose of <1 ng LPS led to tole-
rance, a dose of 100 ng LPS to sensitization with a Th2 immune response and a 
dose of 100 µg to Th1 inflammation.48 
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For the Bet v 1-homologous peanut allergen Ara h 8, a binding to lipid rafts 
and allergen uptake via caveolae was demonstrated. Interestingly, this binding 
was only detected in birch pollen allergic individuals, but not in healthy con-
trols.49 The receptor, however, has not yet been identified.  
5. CONCLUSIONS 
The presented data provide evidence for a clear relationship between mole-
cular structure and allergenicity, although many further influencing factors may 
be involved. Besides the allergen structure, the variety of the source of allergens, 
the matrix, the manner of processing, and with regards to the consumer, the ge-
netic background, the qualitative and quantitative exposure, the route of exposure 
(gastrointestinal tract, respiratory tract, skin), and host-associated additional fac-
tors. Preliminary investigations have been performed to better understand these 
interactions. Since the development of an allergic phenotype depends on many 
factors, it is important to dissect and study the different factors.  
Furthermore, the clinical relevance of the sensitization should be determined, 
since sensitization does not necessarily result in clinical symptoms. Clinical 
problems arise from inter- and intra-individual variability of the level triggering 
allergic reactions.  
A first step is to switch from prick test with mixtures from allergenic 
sources, which can only differentiate between sensitized or non-sensitized, to a 
component-resolved diagnosis, which allows discrimination between the diffe-
rent allergens and, hopefully, to find marker allergens (e.g., Ara h 2) that allow 
severe symptoms to be predicted.50 
ИЗВОД 
ШТА КИКИРИКИ ЧИНИ ЈАКИМ АЛЕРГЕНОМ? 
ARND PETERSEN, WOLF-MEINHARD BECKER и UTA JAPPE 
Division of Clinical and Molecular Allergology, Research Center Borstel, Airway Research Center North 
(ARCN), Member of the German Center for Lung Research, Borstel, Germany 
Алергија  на  кикирики  је  једна  од  најјачих  алергија  на  храну.  До  сада  је  регис-
тровано 12 алергена кикирикија од стране надлежног тела (IUIS Allergen Nomenclature 
Subcommittee). У овом раду описујемо различите алергене кикирикија и факторе који 
доприносе алергености. Кикирики садржи неколико алергена класе I (посебно Ara h 1, 2 
и 3), који одолевају топлотном и протеолитичким разлагању и чине депо протеине. Они 
често изазивају јаке алергијске реакције. Кикирики садржи и алергене класе II (Ara h 5 и 
8), који индукују IgE реактивност која има унакрсно препознавање инхалаторних алер-
гена. Ови алергени изазивају благу до средње јаку алергеност. На јачину симптома могу 
утицати и додатни фактори. Кикирики се састоји од 50 % липида и за неколико алергена 
је  констатовано  асосовање  са  липидима.  На  алергеност  утиче  врста  кикирикија,  гео-
графско порекло и начин обраде за  исхрану. Физиолошки пут алергена, као и меха-
низми интеракције са имуним системом су, такође, модулаторни фактори. Према томе, 
специфична  структура  алергена,  конзистенција,  генетске  варијације,  географско  по-
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рекло и други појачавајући фактори су важни параметри за индукцију и даљи ток алер-
гијске реакције. 
(Примљено 5. октобра 2012, ревидирано 24. јануара 2013) 
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